Holdings
Penn Series Small Cap Growth Fund
As of Jun 30, 2026, Penn Series Small Cap Growth Fund reported 125 positions worth US$97.7M. Largest: Glaukos Corporation, Ligand Pharmaceuticals Incorporated and Tower Semiconductor Ltd. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Glaukos Corporation | 18,246 | US$2.55M | −149 | Jun 30, 2026 |
| Ligand Pharmaceuticals Incorporated | 6,810 | US$2.15M | −237 | Jun 30, 2026 |
| Tower Semiconductor Ltd. | 7,622 | US$1.99M | −1,262 | Jun 30, 2026 |
| Ceco Environmental Corp. | 19,643 | US$1.78M | −160 | Jun 30, 2026 |
| Revolution Medicines, Inc. | 9,270 | US$1.74M | −76 | Jun 30, 2026 |
| Legence Corp. | 19,763 | US$1.68M | −4,036 | Jun 30, 2026 |
| Mirum Pharmaceuticals, Inc. | 13,739 | US$1.61M | −112 | Jun 30, 2026 |
| Spx Technologies, Inc. | 6,391 | US$1.57M | −51 | Jun 30, 2026 |
| Macom Technology Solutions Holdings, Inc. | 3,900 | US$1.48M | −29 | Jun 30, 2026 |
| Osi Systems, Inc. | 6,671 | US$1.46M | +1,313 | Jun 30, 2026 |